Tamoxifen

Tamoxifen

SCHEMBL9121934

CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.Oc1ccccc1.Oc1ccccc1

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Tamoxifen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 13/20 0.95
ESRRG P62508 6/20 0.95
ESR2 Q92731 5/20 0.95
MAPT P10636 3/20 0.95
ESRRB O95718 3/20 0.95
MEN1 O00255 2/20 0.95
TP53 P04637 2/20 0.95
CYP3A4 P08684 2/20 0.95
KMT2A Q03164 2/20 0.95
PGR P06401 2/20 0.95
KDM4E B2RXH2 1/20 0.95
ALDH1A1 P00352 1/20 0.95
LMNA P02545 1/20 0.95
HIF1A Q16665 1/20 0.95
NPSR1 Q6W5P4 1/20 0.95
PLD2 O14939 1/20 0.95
PLD1 Q13393 1/20 0.95
NPC1 O15118 1/20 0.90
NR1I2 O75469 1/20 0.90
PRKD3 O94806 1/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Afimoxifene SCHEMBL640496 0.97 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
SCHEMBL2165503 0.97 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
Afimoxifene SCHEMBL2132301 0.97 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
SCHEMBL15668666 0.97 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
Afimoxifene SCHEMBL9189 0.97 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
Tamoxifen SCHEMBL11899365 0.96 ESR1 (0.97) ESR1ESRRGESR2MAPTESRRB
Tamoxifen SCHEMBL4085 0.95 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
Tamoxifen SCHEMBL17262082 0.95 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
Tamoxifen SCHEMBL1056785 0.95 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB
Tamoxifen SCHEMBL17262111 0.95 ESR1 (1.00) ESR1ESRRGESR2MAPTESRRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5384260-A EARLY DETECTION OF DEVELOPING TAMOXIFEN RESISTANCE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-01-24 US claimed
EP-0547141-A4 1994-01-05 EP claimed
EP-0547141-A1 ONSET OF ANTIESTROGEN RESISTANCE IN BREAST CANCER THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-06-23 EP claimed
WO-1992003973-A1 ONSET OF ANTIESTROGEN RESISTANCE IN BREAST CANCER BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-03-19 WO claimed
US-5384260-A EARLY DETECTION OF DEVELOPING TAMOXIFEN RESISTANCE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-01-24 US disclosed
EP-0547141-A4 1994-01-05 EP disclosed
EP-0547141-A1 ONSET OF ANTIESTROGEN RESISTANCE IN BREAST CANCER THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-06-23 EP disclosed
WO-1992003973-A1 ONSET OF ANTIESTROGEN RESISTANCE IN BREAST CANCER BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-03-19 WO disclosed